Navigation Links
Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes
Date:5/5/2009

p>

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help healthcare professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in Ohio.

This press release contains forward-looking statements about Amylin, Lilly and Alkermes and the investigational drug, exenatide once weekly. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that BYETTA and/or the approval of exenatide once weekly and the revenues generated from BYETTA and/or exenatide once weekly may be affected by competition; unexpected new data; safety and technical issues; pre-clinical trial results; clinical trials, including the clinical trials mentioned in this press release, not being
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. New Data From Head-to-Head Phase 3 Trial Demonstrate That Liraglutide is More Effective Than Exenatide in Treatment of Type 2 Diabetes
2. Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly
3. Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
4. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
5. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
6. KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
7. MichBio Announces Expo Tours; Extends Deadline for Innovator Showcase Applications
8. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
9. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
10. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
11. Nitecs IND Application for Clinical Development With Lodotra Accepted by the FDA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... SANTACRUZ,Calif.,Nov.24/PRNewswire/--Twomoreprest...ion,sleadingonlinejobboardandcareerssiteforlifesci...iversityarenowmembersofthejobboard,joining28otherm...oard, www.biocareercenter.com ,isonlyforpost-gradu...ciencecareersitesontheInternet,BioCareerCenteristh...
(Date:11/24/2009)... Health care employment grew b...e only one to show consistent growth during the U....tals remain in trouble, and health systems are com...nnel, instead of just administrators. , ... care employment continued growing in October desp...
(Date:11/24/2009)... SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxy...on(SFDA)hasapprovedthe,investigationalnewdrugappli...ovativeinsulinformulationtotreatdiabetes.ThisIND,a...alstudy. , Diabetesisadisordercharacteristico...nsofdiabetesoftenresultinseveremicro-and,macro-vas...
(Date:11/24/2009)... TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswire-F...lottoCapitalInc.,aleadingproviderofadvancedlasersy...ityclinicmarkets,todayreportedoperationalandfinanc... , ,Q32009Highlights,-Revenuewas$1.46millioncomp...66.3percentcomparedwith66.1percentinQ3,2008,-Netlo...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
... METTLER TOLEDO invites you to register for our...Chemists and Chemical Engineers. Visit our Webina...inars, as well as a listing of over sixty On-Deman...binars are accessible 24 hours a day, 365 days a y...B) February 14, 2009 -- Each free webinar offers ...
...ing technology provided by GeneSeek Inc. , , LINC... company, will be used for medical-grade source pi...ct, a Minnesota non-profit organization providing ...es. With this technology, GeneSeek, a certified Il...actual high-throughput genotyping, will help Sprin...
.... 13 InterMune, Inc. (Nasdaq: ITMN ) today anno...ng of 3,500,000 shares of its common stock. The l...k on the NASDAQ Global Select Market on February 1...lose on or about February 19, 2009, subject to cus...being sold by the company. , , UBS Investment Ban...
Other Biology Technology:Free Webinars in Chemistry and Chemical Engineering 2Pigs to Be Genotyped to Improve Selection and Breeding for Pancreatic Islet Cell Research 2Pigs to Be Genotyped to Improve Selection and Breeding for Pancreatic Islet Cell Research 3InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock 2
(Date:11/25/2009)...BER 25, 2009 Soil is the linchpin of the environm...meet. Despite that, many students see soil as "jus... Soil science educators are challenged with the ta...e critical importance of soil in the environment. ...arth science teachers at University of Nebraska-Li...
(Date:11/24/2009)... Institute (LRI) today named 12 new grant recipien...cognize innovative work across a broad spectrum of...ivity, novelty, and potential to drive scientific ...he complex disease of systemic lupus. , The 2009...rchers across the nation and include interdiscipli...
(Date:11/24/2009)...merican College of Medical Toxicology (ACMT) have ...ion of the Journal of Medical Toxicology (JMT), ...ch 2010. It was previously published by the Unive...Medical Toxicology , an international, peer-review...and practice of medical toxicology. The quarterly...
Breaking Biology News(10 mins):It's not just dirt! 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2Great HealthWorks CEO Ken Meares Named To Executive Cabinet Of American Heart Association Broward County 26apos 3Bs 2010 Heart Ball Heart Society 60758 1Great HealthWorks CEO Ken Meares Named To Executive Cabinet Of American Heart Association Broward County 26apos 3Bs 2010 Heart Ball Heart Society 60758 2Great HealthWorks CEO Ken Meares Named To Executive Cabinet Of American Heart Association Broward County 26apos 3Bs 2010 Heart Ball Heart Society 60758 3New Web Site on Varicose Veins is Launched by AngioDynamics at American College of Phlebology Congress 60755 1New Web Site on Varicose Veins is Launched by AngioDynamics at American College of Phlebology Congress 60755 2New Web Site on Varicose Veins is Launched by AngioDynamics at American College of Phlebology Congress 60755 3Chelation Therapy Drug Found Safe and Beneficial for Children With Autism 60752 1Chelation Therapy Drug Found Safe and Beneficial for Children With Autism 60752 2
...trations and Issues Voter Rolls and ...KA, Bangladesh, Nov. 26 ,BIO-key International, In...based biometric identification and wireless public... in both prepackaged and customized software,solut...an exclusive,contract for the biometric-based cred...
...ping-out ceremony for the experimental hall of PET...ay light in Hamburg. On occasion of the structural...ter Dr. Annette Schavan and Hamburgs First Mayor O... DESY. Its new light source PETRA III is due to be... the way to a world leading centre for interdiscip...
...research program by Dr. Dariusz Malinowski has him...an alternative to winter wheat pastures. , But th... many parts of the nation, said Malinowski, a Texa...t in Vernon. They are from the Mediterranean Basin...imate is changing here, he said. Its been getting ...
Other Biology News:BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh 2BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh 3BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh 4Brilliant perspectives 2Brilliant perspectives 3Summer-dormant tall fescue grass shows promise for pasture improvements 2Summer-dormant tall fescue grass shows promise for pasture improvements 3
Goat Anti-Human CXCL14 / BRAK Polyclonal Antibody, Unconjugated from R&D Systems
Mouse Anti-G9a / EHMT2 Monoclonal Antibody, Unconjugated, Clone A8620A from R&D Systems
Goat Anti-Mouse IGSF4 Polyclonal Antibody, Unconjugated from R&D Systems
Sheep Anti-Mouse GDF-8 Polyclonal Antibodies, from R&D Systems
Biology Products: